These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 27068564)
1. Autoantibodies against TYMS and PDLIM1 proteins detected as circulatory signatures in Indian breast cancer patients. Gupta P; Suman S; Mishra M; Mishra S; Srivastava N; Kumar V; Singh PK; Shukla Y Proteomics Clin Appl; 2016 May; 10(5):564-73. PubMed ID: 27068564 [TBL] [Abstract][Full Text] [Related]
2. Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer. Qiu C; Duan Y; Wang B; Shi J; Wang P; Ye H; Dai L; Zhang J; Wang X Front Immunol; 2021; 12():698312. PubMed ID: 34489945 [TBL] [Abstract][Full Text] [Related]
3. High-throughput and multi-phases identification of autoantibodies in diagnosing early-stage breast cancer and subtypes. Luo R; Zheng C; Song W; Tan Q; Shi Y; Han X Cancer Sci; 2022 Feb; 113(2):770-783. PubMed ID: 34843149 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of a panel of tumor-associated antigens in breast cancer. Pagaza-Straffon C; Marchat LA; Herrera L; Díaz-Chávez J; Avante MG; Rodríguez YP; Arreola MC; López-Camarillo C Cancer Biomark; 2020; 27(2):207-211. PubMed ID: 31839604 [TBL] [Abstract][Full Text] [Related]
5. Plasma Autoantibodies Associated with Basal-like Breast Cancers. Wang J; Figueroa JD; Wallstrom G; Barker K; Park JG; Demirkan G; Lissowska J; Anderson KS; Qiu J; LaBaer J Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1332-40. PubMed ID: 26070530 [TBL] [Abstract][Full Text] [Related]
6. Identification and validation of new autoantibodies for the diagnosis of DCIS and node negative early-stage breast cancers. Lacombe J; Mangé A; Jarlier M; Bascoul-Mollevi C; Rouanet P; Lamy PJ; Maudelonde T; Solassol J Int J Cancer; 2013 Mar; 132(5):1105-13. PubMed ID: 22886747 [TBL] [Abstract][Full Text] [Related]
7. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer. Liu Y; Liao Y; Xiang L; Jiang K; Li S; Huangfu M; Sun S Int J Clin Oncol; 2017 Apr; 22(2):291-296. PubMed ID: 27778118 [TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against heat shock proteins as biomarkers for the diagnosis and prognosis of cancer. Shi L; Chevolot Y; Souteyrand E; Laurenceau E Cancer Biomark; 2017; 18(2):105-116. PubMed ID: 27983529 [TBL] [Abstract][Full Text] [Related]
9. Detection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer. Liu W; De La Torre IG; Gutiérrez-Rivera MC; Wang B; Liu Y; Dai L; Qian W; Zhang JY Tumour Biol; 2015 Feb; 36(2):1307-12. PubMed ID: 25355596 [TBL] [Abstract][Full Text] [Related]
10. Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis. Liu X; Chai Y; Li J; Ren P; Liu M; Dai L; Qian W; Li W; Zhang JY Tumour Biol; 2014 Mar; 35(3):2661-7. PubMed ID: 24399648 [TBL] [Abstract][Full Text] [Related]
11. Survey of autoantibody responses against tumor-associated antigens in thyroid cancer. Abols A; Ducena K; Zayakin P; Silina K; Kalnina Z; Sadovska L; Tars J; Vilmanis J; Narbuts Z; Eglitis J; Pirags V; Line A Cancer Biomark; 2014; 14(5):361-9. PubMed ID: 25171478 [TBL] [Abstract][Full Text] [Related]
12. Autoantibodies against tumor-associated antigens in the early detection of lung cancer. Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936 [TBL] [Abstract][Full Text] [Related]
13. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma. Zhou SL; Ku JW; Fan ZM; Yue WB; Du F; Zhou YF; Liu YL; Li Y; Tang S; Hu YL; Hu XP; Hou ZC; Liu J; Liu Y; Feng XS; Wang LD Dis Esophagus; 2015; 28(4):371-9. PubMed ID: 24612004 [TBL] [Abstract][Full Text] [Related]
14. Systematic review: Tumor-associated antigen autoantibodies and ovarian cancer early detection. Fortner RT; Damms-Machado A; Kaaks R Gynecol Oncol; 2017 Nov; 147(2):465-480. PubMed ID: 28800944 [TBL] [Abstract][Full Text] [Related]
15. Identification of novel autoantibody signatures and evaluation of a panel of autoantibodies in breast cancer. Qiu C; Wang B; Wang P; Wang X; Ma Y; Dai L; Shi J; Wang K; Sun G; Ye H; Zhang J Cancer Sci; 2021 Aug; 112(8):3388-3400. PubMed ID: 34115421 [TBL] [Abstract][Full Text] [Related]
16. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer. Qin JJ; Wang XR; Wang P; Ren PF; Shi JX; Zhang HF; Xia JF; Wang KJ; Song CH; Dai LP; Zhang JY Asian Pac J Cancer Prev; 2014; 15(6):2635-40. PubMed ID: 24761876 [TBL] [Abstract][Full Text] [Related]
17. Establishment and validation of an immunodiagnostic model for prediction of breast cancer. Qiu C; Wang P; Wang B; Shi J; Wang X; Li T; Qin J; Dai L; Ye H; Zhang J Oncoimmunology; 2020; 9(1):1682382. PubMed ID: 32002291 [TBL] [Abstract][Full Text] [Related]
18. A new method combining sequential immunoaffinity depletion and differential in gel electrophoresis to identify autoantibodies as cancer biomarkers. Grandjean M; Dieu M; Raes M; Feron O J Immunol Methods; 2013 Oct; 396(1-2):23-32. PubMed ID: 23916966 [TBL] [Abstract][Full Text] [Related]
19. Anti-heat shock protein autoantibody profiling in breast cancer using customized protein microarray. Shi L; Gehin T; Chevolot Y; Souteyrand E; Mangé A; Solassol J; Laurenceau E Anal Bioanal Chem; 2016 Feb; 408(5):1497-506. PubMed ID: 26715250 [TBL] [Abstract][Full Text] [Related]
20. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with cervical cancer. Huangfu M; Xu S; Li S; Sun B; Lee KH; Liu L; Sun S Tumour Biol; 2016 Jul; 37(7):8709-14. PubMed ID: 26738866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]